Epitomee Medical (Israel) Performance

EPIT Stock   908.10  11.70  1.27%   
Epitomee Medical holds a performance score of 11 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.06, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Epitomee Medical will likely underperform. Use Epitomee Medical downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to analyze future returns on Epitomee Medical.

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Epitomee Medical are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Epitomee Medical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
  

Epitomee Medical Relative Risk vs. Return Landscape

If you would invest  31,840  in Epitomee Medical on September 3, 2024 and sell it today you would earn a total of  58,970  from holding Epitomee Medical or generate 185.21% return on investment over 90 days. Epitomee Medical is generating 5.3054% of daily returns and assumes 37.8327% volatility on return distribution over the 90 days horizon. Simply put, majority of traded equity instruments are less risky than Epitomee on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Epitomee Medical is expected to generate 50.82 times more return on investment than the market. However, the company is 50.82 times more volatile than its market benchmark. It trades about 0.14 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.2 per unit of risk.

Epitomee Medical Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Epitomee Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Epitomee Medical, and traders can use it to determine the average amount a Epitomee Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1402

Best PortfolioBest EquityEPIT
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 37.83
  actual daily
96
96% of assets are less volatile

Expected Return

 5.01
  actual daily
96
96% of assets have lower returns

Risk-Adjusted Return

 0.14
  actual daily
11
89% of assets perform better
Based on monthly moving average Epitomee Medical is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Epitomee Medical by adding it to a well-diversified portfolio.

Epitomee Medical Fundamentals Growth

Epitomee Stock prices reflect investors' perceptions of the future prospects and financial health of Epitomee Medical, and Epitomee Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Epitomee Stock performance.

About Epitomee Medical Performance

By analyzing Epitomee Medical's fundamental ratios, stakeholders can gain valuable insights into Epitomee Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Epitomee Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Epitomee Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.

Things to note about Epitomee Medical performance evaluation

Checking the ongoing alerts about Epitomee Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Epitomee Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Epitomee Medical is way too risky over 90 days horizon
Epitomee Medical appears to be risky and price may revert if volatility continues
About 57.0% of the company shares are held by company insiders
Evaluating Epitomee Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Epitomee Medical's stock performance include:
  • Analyzing Epitomee Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Epitomee Medical's stock is overvalued or undervalued compared to its peers.
  • Examining Epitomee Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Epitomee Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Epitomee Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Epitomee Medical's stock. These opinions can provide insight into Epitomee Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Epitomee Medical's stock performance is not an exact science, and many factors can impact Epitomee Medical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Epitomee Stock analysis

When running Epitomee Medical's price analysis, check to measure Epitomee Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epitomee Medical is operating at the current time. Most of Epitomee Medical's value examination focuses on studying past and present price action to predict the probability of Epitomee Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epitomee Medical's price. Additionally, you may evaluate how the addition of Epitomee Medical to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital